Dmitry Pershin

666 total citations
51 papers, 261 citations indexed

About

Dmitry Pershin is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Dmitry Pershin has authored 51 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 21 papers in Hematology and 17 papers in Oncology. Recurrent topics in Dmitry Pershin's work include Hematopoietic Stem Cell Transplantation (15 papers), Immunodeficiency and Autoimmune Disorders (15 papers) and CAR-T cell therapy research (13 papers). Dmitry Pershin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Immunodeficiency and Autoimmune Disorders (15 papers) and CAR-T cell therapy research (13 papers). Dmitry Pershin collaborates with scholars based in Russia, United States and Germany. Dmitry Pershin's co-authors include Michael Maschan, Elena Kurnikova, Dmitry Balashov, Anna Shcherbina, Alexey Maschan, Alexei Maschan, K. A. Voronin, А. В. Степанов, Anastasia M. Moysenovich and Eugene G. Maksimov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Dmitry Pershin

37 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitry Pershin Russia 10 130 114 113 53 43 51 261
Sarah Mertlitz Germany 9 125 1.0× 114 1.0× 101 0.9× 59 1.1× 27 0.6× 13 273
Fiona He United States 10 235 1.8× 259 2.3× 165 1.5× 62 1.2× 36 0.8× 33 425
Maddalena Noviello Italy 8 171 1.3× 161 1.4× 84 0.7× 93 1.8× 50 1.2× 21 349
Seungwon Lee South Korea 11 147 1.1× 75 0.7× 59 0.5× 115 2.2× 26 0.6× 17 316
Sibgha Gull Chaudhary United States 8 81 0.6× 162 1.4× 100 0.9× 70 1.3× 15 0.3× 38 302
Nhan Tu United States 9 151 1.2× 167 1.5× 52 0.5× 90 1.7× 47 1.1× 15 310
Andrea Towlerton United States 10 216 1.7× 197 1.7× 168 1.5× 82 1.5× 24 0.6× 27 390
Sabine Hoepner Switzerland 6 181 1.4× 150 1.3× 53 0.5× 111 2.1× 42 1.0× 8 305
Peter Gambell Australia 6 86 0.7× 136 1.2× 118 1.0× 91 1.7× 46 1.1× 11 264
Brynn B. Duncan United States 9 106 0.8× 204 1.8× 32 0.3× 84 1.6× 41 1.0× 17 320

Countries citing papers authored by Dmitry Pershin

Since Specialization
Citations

This map shows the geographic impact of Dmitry Pershin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Pershin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Pershin more than expected).

Fields of papers citing papers by Dmitry Pershin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry Pershin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Pershin. The network helps show where Dmitry Pershin may publish in the future.

Co-authorship network of co-authors of Dmitry Pershin

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry Pershin. A scholar is included among the top collaborators of Dmitry Pershin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry Pershin. Dmitry Pershin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukhinа, Anna, Dmitry Pershin, Dmitry Meleshko, et al.. (2025). 13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies. International Journal of Molecular Sciences. 26(19). 9302–9302.
2.
Larin, Sergey S., et al.. (2025). Experience in developing and scaling a protocol for NK lymphocyte enriched cellular product manufacturing for clinical application. Pediatric Hematology/Oncology and Immunopathology. 24(2). 27–37.
3.
Roppelt, Anna, et al.. (2025). Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency. Frontiers in Immunology. 15. 1523256–1523256.
4.
Pershin, Dmitry, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children. Transplantation and Cellular Therapy. 30(4). 437.e1–437.e11. 1 indexed citations
5.
6.
7.
Mukhinа, Anna, et al.. (2024). Genetic Characteristics of a Large Pediatric Cohort of Patients with Inborn Errors of Immunity: Single-Center Experience. Journal of Clinical Immunology. 44(7). 165–165. 1 indexed citations
8.
Попов, А. М., et al.. (2022). Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(2). 127.e1–127.e9. 6 indexed citations
9.
Kurnikova, Elena, et al.. (2022). The use of adoptive cell therapy for the treatment of SARS-CoV-2 in a patient after allogeneic hematopoietic stem cell transplantation. Pediatric Hematology/Oncology and Immunopathology. 21(2). 112–117.
10.
Pershin, Dmitry, et al.. (2022). Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study. Blood Advances. 6(19). 5582–5588. 4 indexed citations
11.
12.
Balashov, Dmitry, Elena Kurnikova, Dmitry Pershin, et al.. (2021). Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell–Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia. Transplantation and Cellular Therapy. 27(4). 330.e1–330.e9. 12 indexed citations
13.
Laberko, Alexandra, et al.. (2021). Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency. Transplantation and Cellular Therapy. 28(3). 172.e1–172.e4. 1 indexed citations
14.
Moysenovich, Anastasia M., Dmitry Pershin, Eugene G. Maksimov, et al.. (2021). Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival. Frontiers in Molecular Biosciences. 8. 745286–745286. 26 indexed citations
15.
Pershin, Dmitry, et al.. (2020). Development of flow cytometry assay for Wiskott–Aldrich syndrome diagnosis by WASP protein evaluation. Pediatric Hematology/Oncology and Immunopathology. 19(2). 141–151. 1 indexed citations
16.
Pershin, Dmitry, et al.. (2020). Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method. Pediatric Hematology/Oncology and Immunopathology. 19(4). 108–118.
17.
Zvyagin, Ivan V., Dmitry Balashov, Ekaterina A. Komech, et al.. (2020). T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αβ T cell-depleted hematopoietic stem cell transplantation. Bone Marrow Transplantation. 56(4). 900–908. 10 indexed citations
18.
Pomerantseva, Ekaterina, Inna Povolotskaya, Fedor A. Konovalov, et al.. (2020). Complex Multisystem Phenotype With Immunodeficiency Associated With NBAS Mutations: Reports of Three Patients and Review of the Literature. Frontiers in Pediatrics. 8. 577–577. 7 indexed citations
19.
Pershin, Dmitry, et al.. (2019). The phenomenon of reverse mutation in a patient with Wiskott–Aldrich syndrome. Pediatric Hematology/Oncology and Immunopathology. 18(3). 104–111. 1 indexed citations
20.
Maschan, Michael, Zhanna Shekhovtsova, Elena Kurnikova, et al.. (2019). Outcome of αβ T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission. Bone Marrow Transplantation. 55(1). 256–259. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Mertlitz Breakdown of academic impact, for papers by Fiona He Breakdown of academic impact, for papers by Maddalena Noviello Breakdown of academic impact, for papers by Seungwon Lee Breakdown of academic impact, for papers by Sibgha Gull Chaudhary Breakdown of academic impact, for papers by Nhan Tu Breakdown of academic impact, for papers by Andrea Towlerton Breakdown of academic impact, for papers by Sabine Hoepner Breakdown of academic impact, for papers by Peter Gambell Breakdown of academic impact, for papers by Brynn B. Duncan
Rankless by CCL
2026